MNRR1 is a driver of ovarian cancer progression

Cancer progression requires the acquisition of mechanisms that support proliferative potential and metastatic capacity. MNRR1 (also CHCHD2, PARK22, AAG10) is a bi-organellar protein that in the mitochondria can bind to Bcl-xL to enhance its anti-apoptotic function, or to respiratory chain complex IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehade, Hussein, Purandare, Neeraja, Fox, Alexandra, Adzibolosu, Nicholas, Jayee, Shawn, Singh, Aryan, Tedja, Roslyn, Gogoi, Radhika, Aras, Siddhesh, Grossman, Lawrence I., Mor, Gil, Alvero, Ayesha B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860385/
https://www.ncbi.nlm.nih.gov/pubmed/36641875
http://dx.doi.org/10.1016/j.tranon.2023.101623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860385/
https://www.ncbi.nlm.nih.gov/pubmed/36641875
http://dx.doi.org/10.1016/j.tranon.2023.101623

Ejemplares similares